Chemotherapy for hormonally refractory advanced prostate carcinoma. A Comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil
- 15 March 1992
- Vol. 69 (6), 1440-1444
- https://doi.org/10.1002/1097-0142(19920315)69:6<1440::aid-cncr2820690622>3.0.co;2-9
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Mitomycin-C in the treatment of metastatic prostate cancer: report on an EORTC phase II studyWorld Journal of Urology, 1986
- Is there evidence that chemotherapy is of benefit to patients with carcinoma of the prostate?Journal of Clinical Oncology, 1985
- Phase II Trial of Doxorubicin in Bidimensionally Measurable Prostatic AdenocarcinomaJournal of Urology, 1984
- Chemotherapy of hormone-refractory carcinoma of prostate with 5-fluorouracil, adriamycin, and mitomycin CUrology, 1984
- A comparative clinical trial of adriamycin and 5‐fluorouracil in advanced prostatic cancer: Prognostic factors and responseThe Prostate, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958